Home4015 • TADAWUL
add
Jamjoom Pharmaceuticals Fctry Cmpny SJSC
Previous close
SAR 125.40
Day range
SAR 125.80 - SAR 130.00
Year range
SAR 66.00 - SAR 158.20
Market cap
9.09B SAR
Avg Volume
239.10K
P/E ratio
31.07
Dividend yield
-
Primary exchange
TADAWUL
Market news
Financials
Income Statement
Revenue
Net income
(SAR) | Dec 2023info | Y/Y change |
---|---|---|
Revenue | 207.86M | 5.60% |
Operating expense | 72.07M | -4.64% |
Net income | 44.48M | 40.08% |
Net profit margin | 21.40 | 32.67% |
Earnings per share | — | — |
EBITDA | 51.41M | -3.47% |
Effective tax rate | 5.57% | — |
Balance Sheet
Total assets
Total liabilities
(SAR) | Dec 2023info | Y/Y change |
---|---|---|
Cash and short-term investments | 290.24M | 96.96% |
Total assets | 1.65B | 17.50% |
Total liabilities | 249.84M | 30.43% |
Total equity | 1.40B | — |
Shares outstanding | 70.00M | — |
Price to book | 6.25 | — |
Return on assets | 6.75% | — |
Return on capital | 8.07% | — |
Cash Flow
Net change in cash
(SAR) | Dec 2023info | Y/Y change |
---|---|---|
Net income | 44.48M | 40.08% |
Cash from operations | 200.18M | 82.59% |
Cash from investing | -8.76M | 36.26% |
Cash from financing | -84.74K | 99.87% |
Net change in cash | 191.09M | 429.88% |
Free cash flow | 182.91M | — |
About
Founded
1994
Website
Employees
1,027